Book Appointment

Ellacor Micro-Coring in Washington, DC

A Different Approach to Facial Rejuvenation

Patients seeking firmer, smoother-looking skin without a traditional facelift may want to learn about ellacor®, an FDA-cleared device that uses Micro-Coring® technology.

Unlike laser resurfacing, radiofrequency, or ultrasound treatments, ellacor does not use heat or energy to treat skin. Instead, precisely engineered hollow needles remove tiny columns of skin, allowing surrounding tissue to close and remodel during healing.

For patients exploring facial rejuvenation at DC Derm Docs in Washington, DC, understanding this distinction is essential to setting realistic expectations.

How Does Ellacor Work?

During treatment, a medical professional numbs the area and uses the device to remove microscopic cores of skin in a controlled pattern. The body’s natural healing response helps the treated area contract and reorganize.

The goal is to improve the appearance of moderate to severe wrinkles, particularly across the mid and lower face. Unlike conventional microneedling, which punctures skin without removing tissue, micro-coring physically removes small amounts of skin. A procedure may take approximately 30 minutes, although appointment time and treatment planning vary.

Ellacor Micro-Coring in Washington DC

Potential Benefits

Ellacor offers a nonsurgical option for patients bothered by visible facial wrinkles and age-related changes in skin appearance.

Potential benefits include smoother-looking midface and lower-face skin, improvement in the appearance of deeper wrinkles, and gradual refinement as healing progresses. Because no thermal energy is used, the treatment avoids heat-related injury associated with some energy-based devices.

However, ellacor is not a substitute for a surgical facelift, and the degree of tightening varies. Some patients may need a series of treatments; in clinical studies, many underwent three sessions about a month apart.

Who Is a Good Candidate?

The device is cleared for treatment of moderate and severe wrinkles in the mid and lower face in adults age 22 or older with Fitzpatrick skin types I–IV; it is also cleared for fractional skin resurfacing.

Appropriate candidates generally have realistic goals, can follow aftercare instructions, and are willing to allow time for recovery. A consultation should review skin type, treatment goals, medical history, medications, previous cosmetic procedures, and the condition of the proposed treatment area. Safety and effectiveness for Fitzpatrick types V–VI have not been established in the same way; these patients require particular caution and individualized medical advice.

Safety Profile and Recovery

FDA clearance does not mean a procedure is risk-free. Expected short-term effects may include redness, swelling, bruising, tenderness, crusting, tightness, dryness, and pinpoint marks.

Recovery can take days to weeks, depending on treatment settings and individual healing. Less common but important complications include infection, pigment changes, scarring, uneven texture, and anesthesia-related reactions.

The procedure should not be performed during pregnancy or nursing, over active infection or irritated skin, or in certain patients with bleeding disorders, problematic scarring, relevant allergies, or skin conditions.

Recent facial surgery, fillers, Botox, other aesthetic procedures, and blood-thinning medications may also affect eligibility. Never stop prescribed medication without guidance from your treating clinician.

What to Expect at DC Derm Docs

A personalized consultation is the best first step. The dermatology team can assess whether micro-coring is appropriate for your concerns, explain alternatives such as injectables or laser treatments, and discuss expected results, downtime, treatment intervals, and aftercare.

Your consultation is also the time to ask who will perform your treatment and how many sessions are recommended for your goals. For information about facial rejuvenation consultations, contact DC Derm Docs at (202) 822-9591 or visit the practice at 1828 L St NW, Suite 850, Washington, DC 20036.

Clinical references: FDA 510(k) K252752 (indications for use); ellacor official FAQs and Important Safety Information (ellacor.com/faqs/).